Jill Clendening

September 14, 2022

Complementary research, resources, policies improve outcomes for those with substance use disorders: panel

A panel of experts on opioid use disorder (OUD) recently discussed the importance of building recovery ecosystems or networks of resources to respond to the opioid epidemic.

By Jill Clendening
William Russell, MD, second from right, is the principal investigator for a study that uses a plasmid-based therapy to try to selectively desensitize the immune system in people with Type 1 diabetes. Shown here are, from left, Lana Howard, RN, CCRP; Brenna Hammel, RN, CPN; study participant Adam Brooks; Russell; and Robin Perkins, RN. Not pictured: Faith Brendle, RN, CPN, CCRP.
September 1, 2022

Trial participant steps up to help advance diabetes research

Vanderbilt is one of 16 North American sites conducting the Tolerance Using Plasmid in People with Type 1 Diabetes (TOPPLE) study, a phase 1 investigation that tests the safety and dosing of a new plasmid therapy.

By Jill Clendening
Alison Benton, SMB, and David Gaston, MD, PhD, discuss pcr data analysis as they prepare to begin in-house monkey pox testing for VUMC-affiliated practices.
August 31, 2022

Monkeypox testing available for eligible VUMC patients

Vanderbilt University Medical Center is now offering in-house monkeypox polymerase chain reaction (PCR) diagnostic testing for patients who are eligible.

By Jill Clendening
August 25, 2022

Legner named associate vice chair for Network Services

Victor Legner, MD, has been named to the new role of associate vice chair for Network Services for the Department of Medicine at Vanderbilt University Medical Center.

By Jill Clendening
August 25, 2022

Scott named to direct Primary Care Patient Care Center

John Scott, MD, has been named as the new executive medical director of Vanderbilt’s Primary Care Patient Care Center.

By Jill Clendening
August 10, 2022

Burn pit legislation hailed as a victory by physician who became veterans’ advocate

President Joe Biden on Wednesday signed into law a broad expansion of health care benefits for millions of veterans exposed to toxic burn pits, and for Robert Miller, MD, professor of Allergy, Pulmonary and Critical Care Medicine, and his Vanderbilt University Medical Center colleagues, the action is a long-awaited victory.

By Jill Clendening